Teclison Announces the Appointment of Wan Lung Eng As Chief Financial Officer
Teclison, a clinical-stage pharmaceutical company developing novel cancer therapeutics to induce targeted necrosis of solid tumors and convert the tumor into a therapeutic vaccine to enhance cancer remission, today announced the appointment of Wan Lung Eng as Chief Financial Officer. Mr. Eng has over two decades of experience in corporate......